Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions T Kiwamoto, N Kawasaki, JC Paulson, BS Bochner Pharmacology & therapeutics 135 (3), 327-336, 2012 | 194 | 2012 |
Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/CD169 WC Chen, N Kawasaki, CM Nycholat, S Han, J Pilotte, PR Crocker, ... PloS one 7 (6), e39039, 2012 | 140 | 2012 |
Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation N Kawasaki, JL Vela, CM Nycholat, C Rademacher, A Khurana, ... Proceedings of the National Academy of Sciences 110 (19), 7826-7831, 2013 | 130 | 2013 |
Siglecs as sensors of self in innate and adaptive immune responses JC Paulson, MS Macauley, N Kawasaki Annals of the New York Academy of Sciences 1253 (1), 37-48, 2012 | 108 | 2012 |
Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22 F Pfrengle, MS Macauley, N Kawasaki, JC Paulson The Journal of Immunology 191 (4), 1724-1731, 2013 | 93 | 2013 |
In silico-aided design of a glycan ligand of sialoadhesin for in vivo targeting of macrophages CM Nycholat, C Rademacher, N Kawasaki, JC Paulson Journal of the American Chemical Society 134 (38), 15696-15699, 2012 | 80 | 2012 |
The sugar-binding ability of human OS-9 and its involvement in ER-associated degradation K Mikami, D Yamaguchi, H Tateno, D Hu, SY Qin, N Kawasaki, M Yamada, ... Glycobiology 20 (3), 310-321, 2010 | 78 | 2010 |
CD22 regulates adaptive and innate immune responses of B cells N Kawasaki, C Rademacher, JC Paulson Journal of innate immunity 3 (4), 411-419, 2011 | 72 | 2011 |
Repression of phagocytosis by human CD33 is not conserved with mouse CD33 A Bhattacherjee, E Rodrigues, J Jung, M Luzentales-Simpson, ... Communications biology 2 (1), 450, 2019 | 67 | 2019 |
Lactobacillus reuteri surface mucus adhesins upregulate inflammatory responses through interactions with innate C-type lectin receptors KP Bene, DW Kavanaugh, C Leclaire, AP Gunning, DA MacKenzie, ... Frontiers in microbiology 8, 234299, 2017 | 67 | 2017 |
The sugar-binding ability of ERGIC-53 is enhanced by its interaction with MCFD2 N Kawasaki, Y Ichikawa, I Matsuo, K Totani, N Matsumoto, Y Ito, ... Blood, The Journal of the American Society of Hematology 111 (4), 1972-1979, 2008 | 66 | 2008 |
Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activation N Kawasaki, CD Rillahan, TY Cheng, I Van Rhijn, MS Macauley, D Moody, ... The Journal of Immunology 193 (4), 1560-1566, 2014 | 60 | 2014 |
Sugar-binding activity of the MRH domain in the ER α-glucosidase II β subunit is important for efficient glucose trimming D Hu, Y Kamiya, K Totani, D Kamiya, N Kawasaki, D Yamaguchi, I Matsuo, ... Glycobiology 19 (10), 1127-1135, 2009 | 58 | 2009 |
Unmasking of CD22 co-receptor on germinal center B-cells occurs by alternative mechanisms in mouse and man MS Macauley, N Kawasaki, W Peng, SH Wang, Y He, BM Arlian, ... Journal of Biological Chemistry 290 (50), 30066-30077, 2015 | 56 | 2015 |
Targeted delivery of antigen to activated CD169+ macrophages induces bias for expansion of CD8+ T cells LJ Edgar, N Kawasaki, CM Nycholat, JC Paulson Cell chemical biology 26 (1), 131-136. e4, 2019 | 46 | 2019 |
Dectin-2 recognizes mannosylated O-antigens of human opportunistic pathogens and augments lipopolysaccharide activation of myeloid cells A Wittmann, D Lamprinaki, KM Bowles, E Katzenellenbogen, YA Knirel, ... Journal of Biological Chemistry 291 (34), 17629-17638, 2016 | 45 | 2016 |
LC3-Associated Phagocytosis Is Required for Dendritic Cell Inflammatory Cytokine Response to Gut Commensal Yeast Saccharomyces cerevisiae D Lamprinaki, G Beasy, A Zhekova, A Wittmann, S James, J Dicks, ... Frontiers in immunology 8, 1397, 2017 | 41 | 2017 |
Siglec-F is a novel intestinal M cell marker N Gicheva, MS Macauley, BM Arlian, JC Paulson, N Kawasaki Biochemical and biophysical research communications 479 (1), 1-4, 2016 | 40 | 2016 |
Sialidase inhibitors DAMPen sepsis JC Paulson, N Kawasaki Nature biotechnology 29 (5), 406-407, 2011 | 33 | 2011 |
Detection of weak sugar binding activity of VIP36 using VIP36–streptavidin complex and membrane-based sugar chains N Kawasaki, I Matsuo, K Totani, D Nawa, N Suzuki, D Yamaguchi, ... The journal of biochemistry 141 (2), 221-229, 2007 | 33 | 2007 |